EyePoint, Inc.
EYPT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001314102
No open-market purchases or sales by EyePoint, Inc. insiders were filed in the last 90 days; 189 institutions reported holding it in 13F filings for Q3 2026, worth $300.9M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 20, 2026
- $26.6M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +3 vs. previous quarter
- 189
- 13F valueReported value at the end of Q3 2026
- $300.9M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $31.4M
- −27.5% year over year
- Net income, FY2025
- -$232.0M
- No comparable prior period
- Free cash flow, FY2025
- -$243.4M
- No comparable prior period
- Revenue, Q3 FY2026
- $756.0K
- −21.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $232.0M (739.4% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 11.0M
- Shares sold short
- Change
- −10.2M
- −48.2% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding EYPT, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding EYPT at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by EyePoint, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)4:08 PM ET | Aug 18 | Same day | Zaderej Karen L.Director | PPurchase | +10.6K | $4.93 | +$52.3K | +27.5%49.1K after | |
| Jul 2, 2026 (view filing)4:03 PM ET | Jun 30 | 2 days | Ribeiro RamiroChief Medical Officer | SSale | −4.88K | $15.01 | −$73.2K | −100.0%0 after | 2 lots10b5-1 |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Ribeiro RamiroChief Medical Officer | SSale | −2.44K | $15.00 | −$36.6K | −100.0%0 after | 10b5-1 |
| Mar 16, 2026 (view filing) | Mar 16 | Same day | Duker Jay S.President and CEO | PPurchase | +1.50K | $13.15 | +$19.7K | +1.5%100.7K after | |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Ribeiro RamiroChief Medical Officer | SSale | −2.44K | $17.87 | −$43.6K | −100.0%0 after | 10b5-1 |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Ribeiro RamiroChief Medical Officer | SSale | −2.44K | $15.00 | −$36.6K | −100.0%0 after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Ribeiro RamiroChief Medical Officer | SSale | −42.5K | $17.10 | −$727.5K | −100.0%0 after | 10b5-1 |
| Dec 8, 2025 (view filing)4:03 PM ET | Dec 4 | 4 days | Cormorant Asset Management, LP and 2 othersOther: Former 10% Owner | SSale | −60.0K | $15.70 | −$942.2K | −0.7%8.27M after | |
| Dec 5, 2025 (view filing) | Dec 4 | 1 day | Lurker NancyDirector | SSale | −9.30K | $15.11 | −$140.5K | −4.3%206.5K after | 10b5-1 |
| Dec 1, 2025 (view filing) | Nov 26-28 | 5 days | Lurker NancyDirector | SSale | −700 | $14.95 | −$10.5K | −0.3%215.8K after | 2 lots10b5-1 |
Top 10 13F holders, Q3 2026
See all 189 holdersThe largest institutional positions in EyePoint, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 9,366,332 | $30.5M | 0.01% | +9,366,332 | New |
| Suvretta Capital Management, LLC | 8,765,000 | $28.7M | 0.79% | +468,625+5.6% | Added |
| BlackRock, Inc. | 7,982,162 | $26.1M | 0.00% | +518,965+7.0% | Added |
| Federated Hermes, Inc. | 6,934,414 | $22.7M | 0.03% | +1,253,362+22.1% | Added |
| Cormorant Asset Management, LP | 5,750,000 | $18.8M | 1.26% | −1,250,000−17.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 5,000,000 | $16.4M | 0.02% | +172,208+3.6% | Added |
| Vanguard Capital Management LLC | 3,668,374 | $12.0M | 0.00% | +38,122+1.1% | Added |
| Standard Life Aberdeen plc | 3,053,945 | $9.99M | 0.01% | +1,045,143+52.0% | Added |
| State Street Corp | 2,972,889 | $9.72M | 0.00% | +615,344+26.1% | Added |
| Balyasny Asset Management LLC | 2,150,647 | $7.03M | 0.01% | +338,289+18.7% | Added |
Holders of 5% or more of EYPT
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of EyePoint, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G | 10.90%9.37M shares | New | Sep 8, 20261 filing | Sep 8, 2026 | SEC |
| Tang Capital Management LLC | 13G | 9.60%8.25M shares | New | Oct 27, 20261 filing | Oct 27, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.70%6.43M shares | +1.20 ppfrom 6.50% | Oct 22, 20244 filings | Jul 28, 2026 | SEC |
| Cormorant Asset Management, LP | 13G/A | 6.67%5.75M shares | −1.68 ppfrom 8.35% | Dec 14, 20235 filings | Nov 16, 2026 | SEC |
| Franklin Resources Inc | 13G/A | 6.10%4.14M shares | −1.40 ppfrom 7.50% | Feb 1, 20218 filings | Jan 27, 2025 | SEC |